Hide metadata

dc.date.accessioned2015-02-25T14:38:20Z
dc.date.available2015-02-25T14:38:20Z
dc.date.created2015-01-29T11:00:32Z
dc.date.issued2014
dc.identifier.citationNordeng, Hedvig Marie Egeland Ystrøm, Eivind Eberhard-Gran, Malin . Medication safety in pregnancy : results from the MoBa study. Norsk Epidemiologi. 2014, 24(1-2), 161-168
dc.identifier.urihttp://hdl.handle.net/10852/42562
dc.description.abstractThis article summarizes the results of several of our studies on medication safety in pregnancy based on the Norwegian Mother and Child Cohort Study (MoBa). Medications investigated include antidepressants, NSAIDs, codeine, triptans, paracetamol and certain herbals. A major advantage of these studies is that MoBa has information on prescribed medications, over-the-counter medications and herbal medications. Moreover, MoBa enables the possibility of including a disease comparison group, and long-term follow-up into childhood. The size of MoBa enables designs like the sibling-design, which offers important advantages over studies comparing unrelated individuals. The possibility of linking MoBa to nationwide registries like the NorPD and the National Patient Registry enables validation of medication exposures and childhood diagnosis. Pharmacoepidemiological studies are vital to our understanding of the safety of medications in pregnancy, but great care must be taken in the analysis and interpretation of observational data to avoid problems of confounding and bias.en_US
dc.languageEN
dc.language.isoenen_US
dc.publisherNorsk forening for epidemiologi
dc.rightsAttribution 3.0 Unported
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.titleMedication safety in pregnancy : results from the MoBa studyen_US
dc.typeJournal articleen_US
dc.creator.authorNordeng, Hedvig Marie Egeland
dc.creator.authorYstrøm, Eivind
dc.creator.authorEberhard-Gran, Malin
cristin.unitcode185,15,23,10
cristin.unitnameFarmasi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1210675
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Norsk Epidemiologi&rft.volume=24&rft.spage=161&rft.date=2014
dc.identifier.jtitleNorsk Epidemiologi
dc.identifier.volume24
dc.identifier.issue1-2
dc.identifier.startpage161
dc.identifier.endpage168
dc.identifier.urnURN:NBN:no-46966
dc.subject.nviVDP::Epidemiologi medisinsk og odontologisk statistikk: 803
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0803-2491
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/42562/1/Nordeng_2014_Med.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 3.0 Unported
This item's license is: Attribution 3.0 Unported